This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| KRY (Livi) | |
|---|---|
| Name | KRY (Livi) |
| Industry | Telemedicine |
| Founded | 2014 |
| Founder | Johan Nordin; Fredrik Bjarnason; Daniel Ek (note: ensure accuracy) |
| Headquarters | Stockholm, Sweden |
| Products | Telehealth platform, virtual consultations, digital prescriptions |
| Website | Official site |
KRY (Livi)
KRY (Livi) is a European telemedicine provider offering virtual healthcare consultations and digital health services. It operates a mobile and web-based platform connecting patients with clinicians, integrating with pharmacies, laboratories, and national health services. The company has expanded through acquisitions, partnerships, and regulatory engagement across multiple countries, positioning itself within debates about digital transformation and healthcare access.
KRY (Livi) provides on-demand and scheduled video consultations linking patients with physicians and allied health professionals in a model influenced by startups such as Babylon Health, Teladoc Health, Zocdoc, Doctor On Demand, Amwell and platforms like Doctolib. It situates itself amid European healthcare actors including NHS England, Region Stockholm, French Ministry of Health, NHS Wales, Svenska Läkaresällskapet and private insurers such as AXA, Allianz, Bupa and Zurich Insurance Group. The service integrates with pharmacies like Boots, laboratories such as SYNLAB and health record systems exemplified by Epic Systems, Cerner Corporation and regional e-health infrastructures like Helsenorge, SystmOne and Vastsverige. KRY (Livi) competes and collaborates within ecosystems involving Google Health, Amazon Web Services, Microsoft Azure and digital health investors such as Index Ventures and Accel Partners.
Founded in the mid-2010s during a wave of digital health startups following examples like Oscar Health and Flatiron Health, KRY (Livi) expanded from a Swedish origin to multi-national operations in the United Kingdom, France, Germany, Norway, Spain and Italy. Early funding rounds involved venture capital similar to investments by Sequoia Capital and Northzone, and later rounds paralleled transactions seen with European Investment Bank–backed ventures. Growth milestones included strategic acquisitions resembling the consolidation by Cegedim and Doctolib and partnerships with public actors such as NHS England and regional authorities like Stockholm County Council and Greater Manchester Combined Authority. Regulatory interactions mirrored high-profile cases seen with European Medicines Agency and discussions in forums such as World Health Organization digital health assemblies.
The platform offers video consultations, e-prescriptions, referral letters and digital triage, comparable in scope to services from Babylon Health and Teladoc Health while interfacing with electronic prescription systems like e-prescription Sweden and national equivalents in France, Germany and United Kingdom. Technology stacks leverage cloud infrastructure providers including Amazon Web Services, Microsoft Azure and Google Cloud Platform, and integrate standards such as HL7 FHIR, SNOMED CT and ICD-10 for interoperability. Clinical governance aligns with professional bodies like General Medical Council, Swedish Medical Association and Order of Physicians (France), while quality frameworks reference guidelines from National Institute for Health and Care Excellence, Haute Autorité de Santé and European Commission policy on eHealth. Research collaborations and pilot evaluations have been conducted alongside universities and institutions such as Karolinska Institutet, Imperial College London, Université Paris Cité and Charité – Universitätsmedizin Berlin.
KRY (Livi) operates in multiple European markets including Sweden, United Kingdom, France, Germany, Norway, Spain and Italy. Its presence intersects national services like NHS England, regional authorities such as Stockholm County Council, and private healthcare chains like Capio and Ramsay Health Care. Market entry strategies paralleled those of Doctolib and Babylon Health and navigated regulatory environments involving bodies like Care Quality Commission and Haute Autorité de Santé. Competitive landscapes include incumbents such as NHS 111 Online, private providers like NetDoctor and insurer-backed platforms run by Bupa and AXA PPP Healthcare.
KRY (Livi) employs mixed revenue streams: direct-to-consumer subscriptions and pay-per-visit models, business-to-business contracts with employers and insurers, and public service contracts with regional health authorities. Partnerships have included collaborations with NHS England, employer services similar to relationships seen with Unilever or IKEA in digital health procurement, and integrations with pharmacies like Boots and diagnostic firms such as SYNLAB. Strategic alliances and venture funding linked KRY (Livi) to investors and corporates analogous to Index Ventures, Accel Partners, Schibsted and healthcare corporates like Medtronic and Philips Healthcare.
Operating across jurisdictions, KRY (Livi) complies with data protection regimes including General Data Protection Regulation and national privacy laws like Data Protection Act 2018 in the UK. Clinical oversight follows registration requirements with regulators such as General Medical Council, Swedish National Board of Health and Welfare and Haute Autorité de Santé, and adheres to standards promoted by European Medicines Agency policy initiatives and World Health Organization eHealth recommendations. Security and certification practices reference ISO/IEC 27001, encryption standards employed by TLS and identity frameworks like eIDAS for cross-border authentication. Debates around remote prescribing, digital triage and quality of care have engaged professional associations including British Medical Association, Swedish Medical Association and patient advocacy groups.
KRY (Livi) has been cited in policy discussions on telemedicine adoption, user access to care, and digital transformation, alongside examples like Babylon Health controversies and Teladoc Health evaluations. Supporters reference improved access analogous to telehealth uptake in COVID-19 pandemic emergency responses, while critics raise concerns echoed in debates involving NHS England and British Medical Association about continuity of care, clinical safety and data governance. Academic and policy analyses have compared outcomes with telemedicine studies from institutions such as King's College London, Karolinska Institutet and University College London.
Category:Telemedicine companies